Integra LifeSciences Holdings Corporation (IART)
NASDAQ
13.45
+0.24 (+1.82%)
Closed
Oct 19, 2026
Day's Range
13.1113.49
52 wk Range
8.7020.49
Financial Statements - IART - Integra LifeSciences Holdings Corporation
Revenue
1.63B▲ 1.5%
Net Income
-516.47M▼ 7337.7%Net Margin -31.6%
EBITDA
185.95M▼ 3.8%
Free Cash Flow
-45.25M▼ 401.5%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 1.63B | 1.61B | 1.54B | 1.55B | 1.54B | 1.37B |
| Cost of Goods | 803.62M | 728.46M | 656.83M | 587.35M | 597.80M | 520.83M |
| Gross Profit | 831.62M | 882.06M | 884.73M | 970.31M | 944.64M | 851.03M |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | 17.99M | 28.41M | 111.52M | 238.92M | 197.23M | 151.37M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | -513.71M | 3.94M | 3.71M | 12.65M | 61.10M | 4.43M |
| Pre Tax Income | -563.50M | -18.23M | 81.06M | 213.89M | 214.67M | 93.52M |
| Income Tax | -47.02M | -11.29M | 13.32M | 33.34M | 45.60M | -40.37M |
| Net Income | -516.47M | -6.94M | 67.74M | 180.55M | 169.07M | 133.89M |
| EPS Basic | -6.631068 | -0.08999 | 0.866597 | 2.16 | 1.996139 | 1.587583 |
| EPS Diluted | -6.74 | -0.09 | 0.84 | 2.16 | 1.98 | 1.57 |
| Basic Shares Outstanding | 77.88M | 77.16M | 78.16M | 83.58M | 84.70M | 84.33M |
| Diluted Shares Outstanding | 77.88M | 77.16M | 78.16M | 83.58M | 84.70M | 84.33M |
| Ebit | -477.24M | 52.39M | 132.44M | 263.48M | 265.07M | 165.10M |
| Ebitda | 185.95M | 193.28M | 255.95M | 381.14M | 343.11M | 281.13M |
| Net Income Continuous Operations | -516.47M | -6.94M | 67.74M | 180.55M | 169.07M | 133.89M |
| Minority Interests | - | - | - | - | - | - |
| Preferred Stock Dividends | - | - | - | - | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
